Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 7, 2020; 26(5): 524-534
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.524
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.524
Characteristic | n (%)/mean ± SD |
Male/female | 738/264 (73.65/26.35) |
Age at diagnosis (yr) | 28.41 ± 11.05 |
Drinking/not drinking | 58/944 (5.79/94.21) |
Smoking/not smoking | 150/852 (14.97/85.03) |
Body mass index at diagnosis (kg/m2) | 18.58 ± 2.90 |
Year of follow-up (mo) | 53.54 ± 13.10 |
Montreal classification | |
Age at diagnosis (%) | |
A1 | 119 (11.88) |
A2 | 744 (74.25) |
A3 | 139 (13.87) |
Location at diagnosis | |
L1 | 145 (14.47) |
L2 | 104 (10.38) |
L3 | 678 (67.66) |
L4 | 75 (7.49) |
Behavior at diagnosis | |
B1 | 614 (61.28) |
B2 | 185 (18.46) |
B3 | 203 (20.26) |
CRP at diagnosis | 19.84 ± 24.25 |
ESR at diagnosis | 34.58 ± 28.48 |
Alb at diagnosis | 39.14 ± 25.65 |
Previous perianal surgery | 299 (29.84) |
Previous intestinal surgery | 409 (40.82) |
Complication | 287 (28.64) |
Stenosis | 129 (12.87) |
Perforation | 139 (13.87) |
GI bleeding | 19 (1.90) |
Treatment | |
5-aminosalicylic acid | 202 (20.16) |
Immunosuppressants | 746 (74.45) |
Corticosteroids | 529 (52.79) |
Biologics | 462 (46.11) |
EEN | 230 (22.95) |
Surgery within 1 yr after diagnosis | 243(24.25) |
Surgery within the follow-up period | 473 (47.21) |
- Citation: Yao JY, Jiang Y, Ke J, Lu Y, Hu J, Zhi M. Development of a prognostic model for one-year surgery risk in Crohn’s disease patients: A retrospective study. World J Gastroenterol 2020; 26(5): 524-534
- URL: https://www.wjgnet.com/1007-9327/full/v26/i5/524.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i5.524